Serum levels of β2-microglobulin, neopterin, TNF-α and soluble receptors of TNF-α and interleukin-2 in intravenous drug abusers according to HIV-1 status and stage of the HIV-1 infection
Open Access
- 1 January 1998
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 4 (1) , 4-10
- https://doi.org/10.1111/j.1469-0691.1998.tb00327.x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Markers predicting progression of human immunodeficiency virus-related diseaseClinical Microbiology Reviews, 1994
- Laboratory markers and the risk of developing HIV-1 disease among injecting drug usersAIDS, 1994
- Serum β2-microglobulin and prediction of progression to AIDS in HIV infectionThe Lancet, 1992
- Determinants of HIV disease progression: six-year longitudinal study in the Edinburgh haemophilia/HIV cohortThe Lancet, 1991
- Markers for disease progression in intravenous drug users infected with HIV-1AIDS, 1991
- β2-microglobulin levels in drug usersAIDS, 1991
- Immunological and serological markers predictive of progression to AIDS in a cohort of HIV-infected drug usersAIDS, 1990
- The Prognostic Value of Cellular and Serologic Markers in Infection with Human Immunodeficiency Virus Type 1New England Journal of Medicine, 1990
- Elevated neopterin and beta2-microglobulin levels in blood and cerebrospinal fluid occur early in HIV-1 infectionAIDS, 1989
- Neopterin concentrations in cerebrospinal fluid and serum of individuals infected with HIV-1AIDS, 1989